Embrace the innovation in PCI and TAVR - EuroPCR 2022

Описание к видео Embrace the innovation in PCI and TAVR - EuroPCR 2022

The objective of this session is to highlight MicroPort's innovation portfolio in 3 different fields: learn more about the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools, the features and benefits of PCI robot R-ONE and first clinical trial updates in China, and the five-year clinical results of VitaFlow Transcatheter Aortic Valve System.

With Andreas Baumbach, Pieter Smits, Bo Xu, Wei Liu, Mao Chen, Yundai Chen, and Ling Tao.

Sponsored by MicroPortSponsored by MicroPort

Find more content from EuroPCR 2022 here: https://www.pcronline.com/Cases-resou...

#EuroPCR
#PCI
#FirehawkStents
#STEMI
#TAVI

Комментарии

Информация по комментариям в разработке